KAMPALA — XRP Healthcare, a rapidly growing innovator in AI-driven healthcare and mergers and acquisitions, announced Monday it will accelerate its initial public offering, listing on a Canadian stock exchange by the third quarter of 2025.

The company originally planned to go public in 2027 but moved up its timeline to fast-track expansion, unlock new investment opportunities and solidify its position as a global leader in healthcare transformation.

XRP Healthcare’s decision follows several significant developments, including the acquisition of Pharma Ville, a Ugandan pharmacy chain with five wholesale and two retail locations. This acquisition provides direct access to pharmaceutical and medical infrastructure, establishing a foothold in Africa’s projected $259 billion healthcare market.

ARC Group, a globally recognized capital markets advisory firm, is guiding XRP Healthcare through the IPO process. Abraham Cinta, CEO of ARC Group, described the potential impact of becoming a public company: “The spotlight of being a public company is immense, and it could transform their business exponentially.”

Whitney Lynn, chairman of XRP Healthcare, emphasized the company’s momentum: “XRP Healthcare is at a pivotal moment. With our IPO process underway, we’re on track to become a publicly listed company before September.”

The company has forged partnerships with top-tier pharmaceutical and healthcare providers, strengthening its distribution and operational footprint across Africa. XRP Healthcare has also entered an exclusive distribution agreement with Isansys Lifecare for the Patient Status Engine, a wireless medical platform poised to revolutionize care delivery across the continent.

Supporting this vision is the XRPH AI App, a global multilingual digital health assistant available on the Google Play Store and Apple App Store. The app provides AI-generated medical guidance, localized in multiple languages, and is designed to improve access to care in regions with limited healthcare infrastructure.

XRP Healthcare has secured trademark protection in the United Kingdom, European Union, UAE, and Uganda, establishing a recognizable brand in digital healthcare. The company plans to expand into other parts of East Africa, using the frameworks established in Uganda.